Coherus Oncology, Inc. (FRA:8C5)

Germany · Delayed Price · Currency is EUR

1.116

+0.003 (0.27%)

At close: Nov 28, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
Human Pharmaceutical Products	266.96M	Log In	Log In	Log In	Log In	Upgrade
Human Pharmaceutical Products Growth	3.78%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2011 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2011 - 2019
United States	266.96M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	3.78%	Log In	Log In	Log In	Log In	Upgrade